Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

PBM Capital Investments, LLC — Dova Pharmaceuticals, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / PBM Capital Investments, LLC

PBM Capital Investments, LLC

Former 10% Owner at AveXis, Inc. · on record since Feb 19, 2016
10% owner at AveXis, Inc. · on record since Feb 10, 2016
10% owner at Dova Pharmaceuticals, Inc. · on record since Jun 28, 2017

Insider trading activity of PBM Capital Investments, LLC

Transactions on record: 2; since Nov 13, 2017

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Nov 13, 2017

Figures computed from official regulatory filings — methodology.

Companies where PBM Capital Investments, LLC has traded

Dova Pharmaceuticals, Inc.2 tx · Nov 13, 2017

Track record of PBM Capital Investments, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of PBM Capital Investments, LLC

Co-insiders of PBM Capital Investments, LLC

Manning Paul BAveXis, Inc. +1
ALLEN LEE F MD PhDDova Pharmaceuticals, Inc.
BLANKENSHIP DOUGLASDova Pharmaceuticals, Inc.
Dee Thomas J.AveXis, Inc.
DONENBERG PHILIP BAveXis, Inc.
EDELMAN JOSEPHDova Pharmaceuticals, Inc.
Flynn James EAveXis, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Goldman Steven M.Dova Pharmaceuticals, Inc.

Hahn Mark WDova Pharmaceuticals, Inc.

Hoitt JasonDova Pharmaceuticals, Inc.

JEFFS ROGERDova Pharmaceuticals, Inc.

Johannesen MichaelAveXis, Inc.

Kaspar Brian K.AveXis, Inc.

Kearney Terrence CAveXis, Inc.

Knudten Andrew F.AveXis, Inc.

Koh Bong YAveXis, Inc.

Laliberte KevinDova Pharmaceuticals, Inc.

LEFF JONATHAN SAveXis, Inc.

LITALIEN JAMES JAveXis, Inc.

Modi RickAveXis, Inc.

Nagendran SukumarAveXis, Inc.

Nolan Sean P.AveXis, Inc.

Novak Alfred JDova Pharmaceuticals, Inc.

NOVARTIS AGAveXis, Inc.

Nuechterlein CaroleAveXis, Inc.

PERCEPTIVE ADVISORS LLCDova Pharmaceuticals, Inc.

PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDova Pharmaceuticals, Inc.

Sapir AlexDova Pharmaceuticals, Inc.

Session R.A. IIAveXis, Inc.

Siffert Joao MDAveXis, Inc.

Smith Lori J.AveXis, Inc.

Stalfort John A IIIDova Pharmaceuticals, Inc.

Verwiel FrankAveXis, Inc.

WELCH DANIEL GAveXis, Inc.

Wysenski NancyDova Pharmaceuticals, Inc.

ZACCARDELLI DAVIDDova Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Dova Pharmaceuticals, Inc.	Nov 13, 2017	Other	-12,214,953	0.00 USD	$0	SEC
Dova Pharmaceuticals, Inc.	Nov 13, 2017	Other	12,214,953	0.00 USD	$0	SEC